These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 30728311

  • 1. Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities.
    Bekkers S, Delsing CP, Kok SE, van Hulst K, Erasmus CE, Scheffer ART, van den Hoogen FJA.
    Neurology; 2019 Mar 12; 92(11):e1195-e1204. PubMed ID: 30728311
    [Abstract] [Full Text] [Related]

  • 2. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
    Bekkers S, Pruijn IMJ, Van Hulst K, Delsing CP, Erasmus CE, Scheffer ART, Van Den Hoogen FJA.
    Dev Med Child Neurol; 2020 Jul 12; 62(7):861-867. PubMed ID: 32149393
    [Abstract] [Full Text] [Related]

  • 3. Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders.
    Delsing CP, Bekkers S, Erasmus CE, van Hulst K, van den Hoogen FJ.
    Dev Med Child Neurol; 2021 Sep 12; 63(9):1093-1098. PubMed ID: 33844298
    [Abstract] [Full Text] [Related]

  • 4. Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: a randomized controlled trial.
    Bekkers S, Pruijn IMJ, van der Burg JJW, van Hulst K, Kok SE, Delsing CP, Scheffer ART, van den Hoogen FJA.
    Dev Med Child Neurol; 2021 Nov 12; 63(11):1351-1359. PubMed ID: 33997959
    [Abstract] [Full Text] [Related]

  • 5. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep 12; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trial.
    Bekkers S, van Ulsen KJ, M M Adang E, R T Scheffer A, J A van den Hoogen F.
    Dev Med Child Neurol; 2020 Nov 12; 62(11):1302-1308. PubMed ID: 32706122
    [Abstract] [Full Text] [Related]

  • 7. Submandibular gland botulinum neurotoxin A injection for predicting the outcome of submandibular duct relocation in drooling: a retrospective cohort study.
    Kok SE, van Valenberg HFJP, van Hulst K, Jongerius P, Erasmus CE, van den Hoogen FJA.
    Dev Med Child Neurol; 2019 Nov 12; 61(11):1323-1328. PubMed ID: 30854648
    [Abstract] [Full Text] [Related]

  • 8. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.
    Am J Phys Med Rehabil; 2017 Feb 12; 96(2):68-76. PubMed ID: 28099276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep 12; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 12. Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities.
    Van Hulst K, Van Der Burg JJ, Jongerius PH, Geurts AC, Erasmus CE.
    Dev Med Child Neurol; 2020 Mar 12; 62(3):354-362. PubMed ID: 31729034
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and safety of botulinum toxin in comparison with surgery for drooling in paediatric patients with neurological disorders: a systematic review.
    Silva JPS, Faria LV, Almeida RC, Medeiros YL, Guimarães LDA.
    Br J Oral Maxillofac Surg; 2022 Jun 12; 60(5):e691-e701. PubMed ID: 35227530
    [Abstract] [Full Text] [Related]

  • 14. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
    Montgomery J, McCusker S, Lang K, Grosse S, Mace A, Lumley R, Kubba H.
    Int J Pediatr Otorhinolaryngol; 2016 Jun 12; 85():33-9. PubMed ID: 27240493
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of submandibular duct relocation in 91 children with excessive drooling: A prospective cohort study.
    Kok SE, Erasmus CE, Scheffer ART, van Hulst K, Rovers MM, van den Hoogen FJA.
    Clin Otolaryngol; 2018 Dec 12; 43(6):1471-1477. PubMed ID: 29989346
    [Abstract] [Full Text] [Related]

  • 16. Comparing the evidence for botulinum neurotoxin injections in paediatric anterior drooling: a scoping review.
    Orriëns LB, van Hulst K, van der Burg JJW, van den Hoogen FJA, Willemsen MAAP, Erasmus CE.
    Eur J Pediatr; 2024 Jan 12; 183(1):83-93. PubMed ID: 37924348
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ, Dahl JP, Rose AS.
    Int J Pediatr Otorhinolaryngol; 2014 Aug 12; 78(8):1387-92. PubMed ID: 24974144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.